Department of Cardiac Surgery, Rostock University Medical Centre, 18057, Rostock, Germany.
Department of Life, Light and Matter, University of Rostock, 18059, Rostock, Germany.
J Transl Med. 2024 Feb 21;22(1):187. doi: 10.1186/s12967-024-04986-2.
The initial idea of functional tissue replacement has shifted to the concept that injected cells positively modulate myocardial healing by a non-specific immune response of the transplanted cells within the target tissue. This alleged local modification of the scar requires assessment of regional properties of the left ventricular wall in addition to commonly applied measures of global morphological and functional parameters. Hence, we aimed at investigating the effect of cardiac cell therapy with cardiovascular progenitor cells, so-called cardiac induced cells, on both global and regional properties of the left ventricle by a multimodal imaging approach in a mouse model.
Myocardial infarction was induced in mice by ligation of the left anterior descending artery, the therapy group received an intramyocardial injection of 1 × 10 cardiac induced cells suspended in matrigel, the control group received matrigel only. [F]FDG positron emission tomography imaging was performed after 17 days, to assess regional glucose metabolism. Three weeks after myocardial infarction, cardiac magnetic resonance imaging was performed for morphological and functional assessment of the left ventricle. Following these measurements, hearts were excised for histological examinations.
Cell therapy had no significant effect on global morphological parameters. Similarly, there was no difference in scar size and capillary density between therapy and control group. However, there was a significant improvement in contractile function of the left ventricle - left ventricular ejection fraction, stroke volume and cardiac output. Regional analysis of the left ventricle identified changes of wall properties in the scar area as the putative mechanism. Cell therapy reduced the thinning of the scar and significantly improved its radial contractility. Furthermore, the metabolic defect, assessed by [F]FDG, was significantly reduced by the cell therapy.
Our data support the relevance of extending the assessment of global left ventricular parameters by a structured regional wall analysis for the evaluation of therapies targeting at modulation of healing myocardium. This approach will enable a deeper understanding of mechanisms underlying the effect of experimental regenerative therapies, thus paving the way for a successful translation into clinical application.
从最初的功能性组织替代理念,已经转变为这样一种观念,即注射细胞通过目标组织内移植细胞的非特异性免疫反应,积极调节心肌愈合。这种所谓的瘢痕局部修饰需要评估左心室壁的区域特性,除了通常应用的全局形态和功能参数测量。因此,我们旨在通过一种多模态成像方法,在小鼠模型中研究心血管祖细胞(所谓的心脏诱导细胞)的心脏细胞治疗对左心室的全局和局部特性的影响。
通过结扎左前降支在小鼠中诱导心肌梗死,治疗组接受 1×10 个心脏诱导细胞混悬于基质胶中的心肌内注射,对照组仅接受基质胶。[F]FDG 正电子发射断层扫描成像在 17 天后进行,以评估局部葡萄糖代谢。心肌梗死后 3 周,进行心脏磁共振成像以评估左心室的形态和功能。进行这些测量后,切除心脏进行组织学检查。
细胞治疗对全局形态参数没有显著影响。同样,治疗组和对照组之间的瘢痕大小和毛细血管密度也没有差异。然而,左心室的收缩功能(左心室射血分数、每搏量和心输出量)有显著改善。左心室的区域分析确定了瘢痕区域的壁特性变化是潜在的机制。细胞治疗减少了瘢痕变薄,并显著改善了其径向收缩性。此外,细胞治疗显著降低了[F]FDG 评估的代谢缺陷。
我们的数据支持通过结构化的区域壁分析扩展对治疗目标为调节愈合心肌的全局左心室参数的评估的相关性。这种方法将使我们能够更深入地了解实验性再生治疗效果的机制,从而为成功转化为临床应用铺平道路。